Fundraising Fox

Biotech Investors & VC Firms in Global

122 firms in this list, with a median first check of $500K. 34 of them lead rounds. Generated from verified public data and updated continuously.

Andreessen Horowitz
Menlo ParkSeed–Late Stage$500K – $50M
15 people
F-Prime Capital Partners
BostonPre-Seed–Late Stage$3M – $10M
99 people
Khosla Ventures
Menlo ParkPre-Seed–Late Stage$5K – $50M
44 people
Bessemer Venture Partners
LarchmontSeed–Late Stage$50K – $100M
11 people
B4 Capital
Manhattan BeachPre-Seed–Late Stage$10M – $50M
58 people
DCVC (Data Collective)
San FranciscoPre-Seed–Late Stage
11 people
Sofinnova Ventures
Menlo ParkSeed–Late Stage$100K – $15M
43 people
Pillar VC
BostonPre-Seed–Series B$50K – $4M
61 people
SV Health Investors
BostonPre-Seed–Late Stage$1M – $20M
17 people
Draper Associates
Silicon ValleyPre-Seed–Series A
19 people
Beyond Next Ventures
TokyoSeed–Series A
33 people
Source Code Capital
BeijingSeed–Growth
7 people
OrbiMed
New YorkPre-Seed–Late Stage
PharmStars Ventures
BostonPre-Seed–Seed
24 people
Breyer Capital
Menlo ParkPre-Seed–Growth
8 people
OMERS Ventures
TorontoPre-Seed–Series A$3.6M – $18.3M
18 people
Colle Capital Partners
New YorkPre-Seed–Series A$500K – $2M
22 people
Nextech Invest
ZurichSeed–Late Stage$648K – $3.2M
37 people
Sanofi Ventures
CambridgeSeed–Late Stage$5M
17 people
LSP (Life Sciences Partners)
StockholmSeries A–Late Stage$10M – $60M
42 people
MPM BioImpact
BostonPre-Seed–Series C$1M – $15M
34 people
Pitango
Tel AvivPre-Seed–Late Stage$2M – $40M
41 people
Decheng Capital
Silicon ValleySeed–Growth
16 people
Ysios Capital
DenmarkSeries A–Late Stage$5.4M – $21.6M
25 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.